Trump Administration Announces Plan to Change Kidney Care in the U.S.
President Trump signed an executive order to launch Advancing American Kidney Health,
Specifically, the initiative aims to:
The order also calls for the Department of Health and Human Services to:
Source: Nephrology News & Issues
Fresenius Invests in BioIntelliSense
BioIntelliSense is developing a remote, continuous health monitoring data platform. The technology provides clinical insights, predictive analytics and real-time data via medical-grade sensors. Fresenius hopes its investment will help monitoring, treatment and outcomes for kidney disease patients. It will also assist BioIntelliSense with the development of clinical pathways to help patients avoid hospitalization by alerting clinicians to the need for early intervention.
Source: Nephrology News & Issues
Premature Birth May Significantly Increase Risk for Chronic Kidney Disease (CKD) Later in Life
A recent study found that those who were born preterm should have long-term follow up to preserve their renal function over their lifetime. Birth before 37 weeks gestation interrupts the development and maturation of the kidneys. The strongest association between CKD and premature birth was found in those ages 0 to 9 years.
Source: Nephrology News & Issues
Study Finds Persistent Gaps in Chronic Kidney Disease (CKD) Care
Patients with CKD in the U.S. experience “persistent and substantial” gaps in their care, according to a new study. The study found that uncontrolled hypertension and uncontrolled diabetes has not changed in CKD patients from 2006 to 2008 and 2012 to 2014.
Source: Renal & Urology News
Real-World Dialysis Patients Have Worse Prognoses
Dialysis patients in the real world have worse prognoses than those in clinical trials, studies have found. Researchers found that randomized controlled trial (RTC) patients were likely to be younger, and had fewer cases of diabetes, diabetic neuropathy and heart failure.
Source: Renal & Urology News